4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001209191-22-050093
Options or other derivatives
- Chief Medical Officer acquired 18,325 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Kropotova Alexandra Chief Medical Officer | 2022-09-13 | Grant or award · Employee Stock Option (right to buy) | +18,325 | 18,325 | D | ||
Loading xslF345X03/doc4.xml…